March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 31, 2025

95% of New Drugs Lack Lactation Safety Data, Study Finds

Only 5% of new drug approvals included human lactation data, according to researchers calling for improved lactation pharmacokinetics research for breastfeeding women.

Conexiant

March 31, 2025

Long-Term Antidepressant Use Affects Body Weight

"Given the global obesity epidemic and the widespread use of antidepressants, weight management and metabolic monitoring should be encouraged and integrated into depression follow-up guidelines alongside antidepressant prescriptions," the researchers concluded.

Conexiant

March 28, 2025

Pregnancy Diet Influences Child Development Outcomes

Maternal dietary patterns during pregnancy significantly influenced neurodevelopmental disorders, with findings indicating a strong association with ADHD and autism diagnoses.

Conexiant

March 28, 2025

Triplication of Chromosome 3p24.3p23 in a Child with Autism: What's Your Diagnosis?

Case report highlights a rare 3p24.3p23 triplication in syndromic autism spectrum disorder.

Conexiant

March 27, 2025

Does Religion Protect Mental Health?

Study reveals that religiousness is linked to lower depression rates among U.S. college students, with significant variations based on sexual orientation and religious affiliation.

Conexiant

March 27, 2025

FDA Examines Stimulant Use Trends

The FDA reviews rising adult prescription stimulant use, ongoing shortages, and efforts to ensure appropriate access and minimize nonmedical use.

Conexiant

March 27, 2025

New Review Explores Hormone Therapy for Mood Disorders

Women with PMDD, PND, and menopausal depression may benefit from hormone therapy, suggest investigators.

Conexiant

March 27, 2025

Education Level Linked to Poststroke Decline

Researchers found that stroke survivors with higher education levels experienced faster poststroke decline in executive function despite better initial cognitive performance.

Conexiant